No connection

Search Results

PLUR vs RMTI

PLUR
Pluri Inc.
BEARISH
Price
$3.51
Market Cap
$35.3M
Sector
Healthcare
AI Confidence
95%
RMTI
Rockwell Medical, Inc.
BEARISH
Price
$0.91
Market Cap
$36.0M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
PLUR
--
RMTI
--
Forward P/E
PLUR
-1.85
RMTI
13.05
P/B Ratio
PLUR
-2.4
RMTI
0.97
P/S Ratio
PLUR
26.35
RMTI
0.52
EV/EBITDA
PLUR
-2.58
RMTI
-9.4

Profitability

Gross Margin
PLUR
40.63%
RMTI
16.89%
Operating Margin
PLUR
-3285.86%
RMTI
-2.17%
Profit Margin
PLUR
0.0%
RMTI
-7.67%
ROE
PLUR
--
RMTI
-15.28%
ROA
PLUR
-50.6%
RMTI
-5.04%

Growth

Revenue Growth
PLUR
7.0%
RMTI
-25.6%
Earnings Growth
PLUR
--
RMTI
--

Financial Health

Debt/Equity
PLUR
--
RMTI
0.34
Current Ratio
PLUR
0.43
RMTI
3.98
Quick Ratio
PLUR
0.39
RMTI
3.46

Dividends

Dividend Yield
PLUR
--
RMTI
--
Payout Ratio
PLUR
0.0%
RMTI
0.0%

AI Verdict

PLUR BEARISH

PLUR exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.40, indicating negative shareholder equity. The company is facing a severe liquidity crisis with a current ratio of 0.43, suggesting it cannot meet its short-term obligations. While recent quarterly earnings have beaten estimates, the operating margin of -3285.86% and a bearish technical trend (0/100) underscore a high risk of insolvency or significant shareholder dilution. The valuation is disconnected from fundamentals, trading at a high Price/Sales multiple of 26.35 despite sluggish revenue growth.

Strengths
Recent quarterly earnings beats (3 of last 4 quarters)
Positive YoY EPS growth (+71%)
Gross margin remains positive at 40.63%
Risks
Negative equity (P/B -2.40) indicating insolvency risk
Severe liquidity shortage (Current Ratio 0.43)
Catastrophic operating losses (-3285.86% margin)
RMTI BEARISH

RMTI exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness across profitability and operational efficiency. Despite a strong current ratio of 3.98 and low debt-to-equity, the company is suffering from a significant revenue contraction of -25.60% YoY and consistent earnings misses (0/4 beats in the last year). The disconnect between the analyst target price of $3.00 and the actual fundamental decay, coupled with bearish insider selling, suggests a high-risk speculative profile.

Strengths
Strong short-term liquidity with a current ratio of 3.98
Low leverage with a Debt/Equity ratio of 0.34
Trading slightly below book value (P/B 0.97)
Risks
Severe revenue decline (-25.60% YoY and Q/Q)
Consistent failure to meet earnings estimates (Average surprise -80.56%)
Negative ROE (-15.28%) and negative profit margins

Compare Another Pair

PLUR vs RMTI: Head-to-Head Comparison

This page compares Pluri Inc. (PLUR) and Rockwell Medical, Inc. (RMTI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile